webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

H-D-Orn(N3)-OH HCl

  CAS No.: 1858224-08-4   Cat No.: BADC-01777   Purity: >98% 4.5  

H-D-Orn(N3)-OH hydrochloride is an azido-modified amino acid linker precursor facilitating selective bioorthogonal conjugation in antibody-drug conjugate development.

H-D-Orn(N3)-OH HCl

Structure of 1858224-08-4

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C5H11ClN4O2
Molecular Weight
194.62
Storage
Store at 2-8 °C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
D-2-amino-5-azido-pentanoic acid.HCl; D-Azidonorvaline.HCl; H-D-Nva(5-N3)-OH.HCl; H-D-Orn(N3).HCl; H-D-Orn(N3)-OH hydrochloride; H-D-Nva(N3)-OH.HCl; 5-Azido-D-norvaline hydrochloride; N-delta-Azido-D-ornithine hydrochloride; (R)-2-Amino-5-azidopentanoic acid hydrochloride; D-Orn(N3) HCl; N-delta-Azido-D-norvaline hydrochloride; H-Orn(N3).HCl; D-Norvaline, 5-azido-, hydrochloride (1:1)
IUPAC Name
(2R)-2-amino-5-azidopentanoic acid;hydrochloride
Canonical SMILES
C(C[C@H](C(=O)O)N)CN=[N+]=[N-].Cl
InChI
InChI=1S/C5H10N4O2.ClH/c6-4(5(10)11)2-1-3-8-9-7;/h4H,1-3,6H2,(H,10,11);1H/t4-;/m1./s1
InChIKey
HBDWAEAKFVAPSA-PGMHMLKASA-N
Storage
Store at 2-8 °C

H-D-Orn(N3)-OH hydrochloride is a synthetic compound derived from the amino acid ornithine, with the addition of an azide (N3) group. This modification makes it a valuable building block in bioorthogonal chemistry, particularly for click chemistry applications. The azide group is highly reactive and can undergo a copper-free reaction with dibenzocyclooctyne (DBCO) groups or other suitable partners. This property allows H-D-Orn(N3)-OH hydrochloride to be used in the creation of bioconjugates, including targeted drug delivery systems and peptide-based therapeutics. Its ability to form covalent bonds with azide-reactive molecules makes it a useful tool in the design of selective drug conjugates, enhancing therapeutic specificity while minimizing off-target effects.

A key application of H-D-Orn(N3)-OH hydrochloride is in the development of peptide-drug conjugates (PDCs) for targeted cancer therapy. The compound can be conjugated to cancer-targeting peptides or antibodies, enabling the selective delivery of cytotoxic agents directly to tumor cells. The azide group on H-D-Orn(N3)-OH hydrochloride reacts efficiently with DBCO-functionalized payloads, ensuring precise and stable conjugation. This approach allows for the release of chemotherapeutic agents specifically within the tumor environment, enhancing therapeutic efficacy while reducing systemic toxicity. This makes H-D-Orn(N3)-OH hydrochloride an important tool in the development of next-generation cancer treatments, where precision is crucial.

In addition to its role in targeted therapies, H-D-Orn(N3)-OH hydrochloride is also used in chemical biology for studying protein interactions and cellular processes. The azide group can be used to tag proteins or other biomolecules, facilitating the study of molecular interactions in living systems. By conjugating H-D-Orn(N3)-OH hydrochloride to proteins, researchers can investigate protein-protein interactions, enzyme activity, and the dynamics of cellular signaling pathways. This application is particularly valuable in drug discovery and the identification of new therapeutic targets, as it allows for the monitoring of real-time biological processes with high specificity.

H-D-Orn(N3)-OH hydrochloride also finds applications in the development of diagnostic tools, particularly in molecular imaging and in vivo tracking. The azide group can be used for the selective labeling of biomolecules with imaging agents such as fluorescent dyes, allowing for non-invasive monitoring of molecular processes in living organisms. By incorporating H-D-Orn(N3)-OH hydrochloride into diagnostic probes, it becomes possible to track disease progression, such as tumor growth or inflammation, in real-time. This application is valuable for personalized medicine, where precise monitoring of treatment responses is essential for optimizing therapeutic strategies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: H-L-Lys(N3-Gly)-OH | Me-Tet-PEG9-COOH | N3-L-Cit-OH DCHA | 4-Azido-d-homoalanine | (2S,4S)-Fmoc-L-Pro(4-NHPoc)-OH | MDTF (free acid) | Trisulfo-Cy3 Methyltetrazine | Boc-L-Tyr(2-azidoethyl)-OH | N3-Gly-Aeg(Fmoc)-OH | Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br | H-D-Orn(N3)-OH HCl
Send Inquiry
Verification code
Inquiry Basket